Enerpac Tool
EPAC
Precision Drilling
PDS
Halozyme Therapeutics
HALO
Workday
WDAY
Lantheus
LNTH
US Stock MarketDetailed Quotes
KNSA Kiniksa Pharmaceuticals International
- 23.190
- -0.220-0.94%
Close Mar 25 16:00 ET
- 23.190
- 0.0000.00%
Post 16:05 ET
1.68BMarket Cap-38.65P/E (TTM)
23.630High23.010Low363.12KVolume23.230Open23.410Pre Close8.43MTurnover1.56%Turnover RatioLossP/E (Static)72.64MShares28.15052wk High3.84P/B539.21MFloat Cap16.56052wk Low--Dividend TTM23.25MShs Float32.880Historical High--Div YieldTTM2.65%Amplitude5.010Historical Low23.212Avg Price1Lot Size
About Kiniksa Pharmaceuticals International Company
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
Company Profile
SymbolKNSA
Company NameKiniksa Pharmaceuticals International
Listing DateMay 24, 2018
Issue Price18.00
Founded2024
CEOMr. Sanj K. Patel
MarketNASDAQ
Employees315
Fiscal Year Ends12-31
Address23 Old Bond Street,3rd Floor
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW1S 4PZ
Phone44-781-431-9100
Websitehttps://www.kiniksa.com
Company Executives
- Name
- Position
- Salary
- Sanj K. Patel
- Chief Executive Officer and Chairman of the Board
- 5.30M
- Ross Moat
- Senior Vice President and Chief Commercial Officer
- --
- John F. Paolini, M.D.,PhD
- Senior Vice President and Chief Medical Officer
- 1.79M
- Mark Ragosa
- Senior Vice President and Chief Financial Officer
- --
- Eben Tessari
- Senior Vice President and Chief Operating Officer
- 1.75M
- Michael R. Megna
- Chief Accounting Officer and Group Vice President, Finance
- --
- Meta Cantey Boyd
- Director
- --
- Dr. Richard S. Levy,M.D.
- Independent Director
- 459.75K
- Dr. Felix J. Baker,PhD
- Lead Independent Director
- 411.06K
- Dr. Barry D. Quart,Pharm.D.
- Independent Director
- 372.55K
- Thomas R. Malley
- Independent Director
- 380.36K
- G. Bradley Cole
- Independent Director
- 365.36K
- Tracey L. McCain, Esq.
- Independent Director
- 365.36K
- Kimberly J. Popovits
- Independent Director
- 362.66K
- Dr. Stephen R. Biggar,M.D.,PhD
- Independent Director
- 371.96K